Sang Mok Lee acquired 46% of stake in BiocurePharm Corporation from Biocure Technology Inc..
Sang Mok Lee completed the acquisition of 46% of stake in BiocurePharm Corporation from Biocure Technology Inc. (CNSX:CURE) on May 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -25.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.03M | |
+17.21% | 21.27B | |
+7.81% | 2.79B | |
+48.26% | 2.36B | |
+10.75% | 1.85B | |
+40.45% | 1.54B | |
-20.25% | 694M | |
-3.09% | 303M | |
+16.85% | 107M | |
-26.67% | 65.33M |